ESSA Pharma Inc (EPIX)
6.25
-0.15
(-2.34%)
USD |
NASDAQ |
Apr 24, 16:00
6.46
+0.21
(+3.36%)
After-Hours: 20:00
ESSA Pharma Cash from Financing (TTM): 0.1129M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 0.1129M |
September 30, 2023 | -0.0682M |
June 30, 2023 | -0.0891M |
March 31, 2023 | -0.0487M |
December 31, 2022 | 0.1691M |
September 30, 2022 | 0.2527M |
June 30, 2022 | 0.3007M |
March 31, 2022 | 0.4849M |
December 31, 2021 | 141.94M |
September 30, 2021 | 141.99M |
June 30, 2021 | 187.75M |
March 31, 2021 | 187.61M |
December 31, 2020 | 45.96M |
September 30, 2020 | 41.78M |
June 30, 2020 | 49.61M |
March 31, 2020 | 48.12M |
December 31, 2019 | 47.33M |
September 30, 2019 | 50.56M |
June 30, 2019 | -3.841M |
Date | Value |
---|---|
March 31, 2019 | -3.205M |
December 31, 2018 | 20.65M |
September 30, 2018 | 21.31M |
June 30, 2018 | 21.75M |
March 31, 2018 | 22.35M |
December 31, 2017 | 4.350M |
September 30, 2017 | 12.33M |
June 30, 2017 | 12.69M |
March 31, 2017 | 12.67M |
December 31, 2016 | 26.81M |
September 30, 2016 | 22.74M |
June 30, 2016 | 22.76M |
March 31, 2016 | 23.09M |
December 31, 2015 | 14.28M |
September 30, 2015 | 12.59M |
June 30, 2015 | 17.32M |
March 31, 2015 | 18.12M |
December 31, 2014 | 7.742M |
September 30, 2014 | 5.659M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-3.841M
Minimum
Jun 2019
187.75M
Maximum
Jun 2021
49.47M
Average
41.78M
Median
Sep 2020
Cash from Financing (TTM) Benchmarks
Acasti Pharma Inc | 7.359M |
Aurinia Pharmaceuticals Inc | -5.13M |
Edesa Biotech Inc | 2.224M |
Lexaria Bioscience Corp | 6.862M |
Xenon Pharmaceuticals Inc | 353.52M |